Bessemer Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-55
Closed -$4K 2747
2024
Q3
$4K Buy
+55
New +$3.77K ﹤0.01% 2053
2024
Q2
Sell
-11,830
Closed -$816K 2162
2024
Q1
$816K Sell
11,830
-13,440
-53% -$907K ﹤0.01% 704
2023
Q4
$1.57M Buy
25,270
+6,330
+33% +$354K ﹤0.01% 542
2023
Q3
$1.06M Buy
18,940
+9,352
+98% +$526K ﹤0.01% 611
2023
Q2
$484K Buy
+9,588
New +$510K ﹤0.01% 827
2022
Q4
Sell
-89
Closed -$6K 2184
2022
Q3
$6K Buy
+89
New +$6.14K ﹤0.01% 1683
2021
Q4
Sell
-143
Closed -$9K 2006
2021
Q3
$9K Buy
+143
New +$9.76K ﹤0.01% 1418

Other funds holding AXNX

Bessemer Group's AXNX Position: Q4 2024 in Review

Bessemer Group sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 55 shares — an estimated $4K sold.

Bessemer Group first reported a position in AXNX in Q3 2021 and held it in 7 quarters. The position peaked at $1.57M in Q4 2023. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Bessemer Group reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Bessemer Group sold 55 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $4K.
  • Bessemer Group first reported a position in Axonics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • Bessemer Group's Axonics, Inc. Common Stock position peaked at $1.57M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Bessemer Group's 13F filing for Q4 2024, filed 13 Feb 2025.